Company webinar

Radiopharm Theranostics (ASX:RAD)

Watch our webinar with Radiopharm Theranostics, featuring Managing Director and CEO Riccardo Canevari. A presentation followed by live Q&A with the audience.

Date
November 26, 2024
Time
Where
Online
Entry
Free
Riccardo Canevari
Riccardo Canevari
Managing Director and CEO, Radiopharm Theranostics (ASX:RAD)

About the company

Radiopharm Theranostics (ASX “RAD”) is a clinical stage radiopharmaceutical company developing Therapeutic and Imaging products using peptides, small molecules, nanobodies and antibodies. With three molecules in clinical stage and three molecules in late preclincial, RAD has a very deep pipeline of innovative radiopharmaceuticals.

Key topics

  • Funding and key investors
  • Dual listing at Nasdaq
  • Commercial potential for the 3 clinical programs.

Watch the recording

More webinars

All webinars →

Go beyond the presentation

Management tells one side of the story. Sharewise clients get independent research and Advisor access across ASX, US and global markets.

Explore our services →